Psychiatry and Neurology, Neurology · Albany, NY
NPI
1679937338
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
47 New Scotland Ave Dept of Neurology
Albany, NY, 12208
Phone (518) 262-5377
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
16,891 services
Medicare patients, 2024
472
Average age 75
Drug cost, 2024
$943K
1,793 prescriptions
Company payments, 2025
$2,394
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary Volkell was code J0585 (injection, onabotulinumtoxina, 1 unit), 12,930 times for 28 patients. In total Gary Volkell billed 16,891 services in 36 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 12,930 | 28 | $4.88 | $63K |
| 99215 Office E&M - Established | Office | 411 | 262 | $145.88 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 319 | 226 | $14.22 | $4,538 |
| 99483 Office/Outpatient Services | Office | 172 | 135 | $212.15 | $36K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 147 | 95 | $28.83 | $4,239 |
| 99205 Office E&M - New | Office | 59 | 59 | $176.42 | $10K |
| 95874 Musculoskeletal | Office | 59 | 25 | $68.70 | $4,053 |
| 64616 Musculoskeletal | Office | 51 | 19 | $188.49 | $9,613 |
| 64646 Musculoskeletal | Office | 45 | 17 | $72.47 | $3,261 |
| 99223 Hospital E&M - Initial | Facility | 40 | 40 | $145.70 | $5,828 |
| 99233 Hospital E&M - Subsequent | Facility | 25 | 17 | $99.79 | $2,495 |
| 99441 Telephone Services | Office | 22 | 19 | $50.65 | $1,114 |
| 99406 Behavioral Health Services | Office | 21 | 20 | $15.64 | $328 |
| 99442 Telephone Services | Office | 21 | 18 | $77.37 | $1,625 |
| 99214 Office E&M - Established | Office | 12 | 11 | $105.13 | $1,262 |
By year: 2022 $154K for 8,108 services; 2023 $181K for 13,535 services; 2024 $229K for 16,891 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gary Volkell prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 281 prescriptions and refills. In total Gary Volkell wrote 1,793 Medicare prescriptions that cost $943K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 281 | 758 | 94 | $14K |
| Primidone Generic | 142 | 422 | 48 | $6,192 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 136 | 365 | 42 | $14K |
| Memantine Hcl Generic | 114 | 292 | 39 | $4,433 |
| Propranolol Hcl Er Propranolol Hcl | 110 | 294 | 31 | $10K |
| Gabapentin Generic | 108 | 272 | 40 | $3,115 |
| Donepezil Hcl Generic | 94 | 266 | 33 | $1,087 |
| Clonazepam Generic | 57 | 118 | 15 | $882 |
| Escitalopram Oxalate Generic | 51 | 143 | 17 | $613 |
| Levetiracetam Generic | 45 | 133 | 12 | $2,324 |
| Quetiapine Fumarate Generic | 42 | 97 | 19 | $1,427 |
| Pregabalin Generic | 39 | 103 | 14 | $2,824 |
| Baclofen Generic | 36 | 67 | Under 11 | $1,929 |
| Amantadine Amantadine Hcl | 32 | 76 | Under 11 | $1,829 |
| Ingrezza Valbenazine Tosylate | 29 | 29 | Under 11 | $233K |
Brand drugs: 160 claims; generic drugs: 1,633 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary Volkell $2,394 ($2,394 in general payments such as food, travel and fees) from 14 companies. The largest payer was Ipsen Innovation with $909.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Innovation IPN.PA | 5 | $909 |
| Abbvie Inc. ABBV | 13 | $242 |
| Eisai Inc. 4523.T | 4 | $223 |
| Amneal Pharmaceuticals LLC AMRX | 14 | $220 |
| Biogen, Inc. BIIB | 10 | $203 |
| Supernus Pharmaceuticals, Inc. SUPN | 3 | $186 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $159 |
| Genentech USA, Inc. ROG.SW | 2 | $58 |
| Tanabe Pharma America, Inc. | 2 | $51 |
| Lilly USA, LLC LLY | 2 | $47.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.